EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nodal Expansion, Tumor Infiltration and Exhaustion of Neoepitope-Specific Th Cells After Prophylactic Peptide Vaccination and Anti-CTLA4 Therapy in Mouse Melanoma B16

Alexandra V Shabalkina, Anna V Izosimova, Ekaterina O Ryzhichenko, Elizaveta V Shurganova, Daria S Myalik, Sofia V Maryanchik iD, Valeria K Ruppel, Dmitriy I Knyazev, Nadezhda R Khilal, Ekaterina V Barsova, Irina A Shagina, George V Sharonov

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alexandra V Shabalkina und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Translational Medicine, Pirogov Russian National Research Medical University, 1 Ostrovityanova, Moscow 117997, Russia. Hauptthemen laut MEDLINE: CTLA-4 Antigen, Melanoma, Experimental, Cancer Vaccines, Lymph Nodes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RSF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptide vaccines possess several advantages over mRNA vaccines but are generally less effective at inducing antitumor immunity. The bottlenecks limiting peptide vaccine efficacy could be elucidated by tracking and comparing vaccine-induced T-lymphocytes in successful and unsuccessful cases. Here we have applied our recent database of neoantigen-specific T cell receptors (TCRs) to profile tumor-specific T cells following vaccination with a neoantigen peptide vaccine and to correlate this with the response. Mice were vaccinated prophylactically with p30 peptide encoding B16 melanoma neoantigen (K739N mutation in Kif18b gene). The B16F0 melanoma in the vaccinated mice was additionally treated by a CTLA-4 checkpoint blockade. T cells from the tumors, tumor-draining lymph nodes (tdLNs) and vaccine depots were isolated, phenotyped, sorted by subsets and sequenced for TCR repertoires. The vaccine induced the accumulation of tumor-specific CD4+ Th cells in the tdLNs, while in the tumors these cells were present and their frequencies were not changed by the vaccine. These cells also accumulated at the vaccine depots, where they were phenotypically skewed by the vaccine components; however, these effects were minor due to approximately 50-fold lower cell quantities compared to the tdLNs. Only some of the p30-specific Th cells showed tumoricidal activity, as revealed by the reverse correlation of their frequencies in the tdLNs with the tumor size. The CTLA-4 blockade did not affect the tumor growth or the frequencies of tumor-specific cells but did stimulate Th cell motility. Thus, we have shown that tumor-specific Th clones accumulate and/or expand in the tdLNs, which correlates with tumor suppression but only for some of these clones. Tumor infiltration by these clones is not correlated with the growth rate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CTLA-4 AntigenMelanoma, ExperimentalCancer VaccinesLymph NodesVaccines, SubunitT-Lymphocytes, Helper-InducerAnimalsMiceMice, Inbred C57BLVaccinationFemaleAntigens, NeoplasmLymphocytes, Tumor-InfiltratingCell Line, TumorReceptors, Antigen, T-Cell

Stichwörter der Autor:innen

B16 melanomaTCR repertoirepeptide anticancer vaccine

Substanzen

CTLA-4 AntigenCancer VaccinesVaccines, SubunitAntigens, NeoplasmReceptors, Antigen, T-CellCtla4 protein, mouse

Autor:innen und Institutionen

  • Research Institute of Translational Medicine, Pirogov Russian National Research Medical University, 1 Ostrovityanova, Moscow 117997, Russia.
  • Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, 16/10 Miklukho-Maklaya, Moscow 117997, Russia.
  • Research Institute of Experimental Oncology and Translational Biomedicine, Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Sq., Nizhny Novgorod 603950, Russia.
  • Pathoanatomical Department, Nizhny Novgorod Regional Clinical Cancer Hospital, Nizhny Novgorod 603126, Russia.
  • Molecular Genetics Laboratory, The University Clinic, Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Sq., Nizhny Novgorod 603950, Russia.

ORCID-Profile: Sofia V Maryanchik

Förderung

  • RSF

Zitieren

APA

Shabalkina, A. V., Izosimova, A. V., Ryzhichenko, E. O., Shurganova, E. V., Myalik, D. S., Maryanchik, S. V., Ruppel, V. K., Knyazev, D. I., Khilal, N. R., Barsova, E. V., Shagina, I. A., & Sharonov, G. V. (2025). Nodal Expansion, Tumor Infiltration and Exhaustion of Neoepitope-Specific Th Cells After Prophylactic Peptide Vaccination and Anti-CTLA4 Therapy in Mouse Melanoma B16. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136453

Vancouver

Shabalkina AV, Izosimova AV, Ryzhichenko EO, Shurganova EV, Myalik DS, Maryanchik SV, et al. Nodal Expansion, Tumor Infiltration and Exhaustion of Neoepitope-Specific Th Cells After Prophylactic Peptide Vaccination and Anti-CTLA4 Therapy in Mouse Melanoma B16. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136453

BibTeX
@article{Shabalkina2025,
  author = {Shabalkina, Alexandra V and Izosimova, Anna V and Ryzhichenko, Ekaterina O and Shurganova, Elizaveta V and Myalik, Daria S and Maryanchik, Sofia V and Ruppel, Valeria K and Knyazev, Dmitriy I and Khilal, Nadezhda R and Barsova, Ekaterina V and Shagina, Irina A and Sharonov, George V},
  title = {Nodal Expansion, Tumor Infiltration and Exhaustion of Neoepitope-Specific Th Cells After Prophylactic Peptide Vaccination and Anti-CTLA4 Therapy in Mouse Melanoma B16},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136453}
}
Kostenlos starten →